What's Happening?
Neogen Corporation has renewed its sponsorship with the United States Equestrian Federation to continue advancing equine health education. This collaboration focuses on developing educational materials for the prevention and treatment of equine botulism, a serious neuromuscular condition in horses. Neogen, a leader in equine health, manufactures BotVax® B, the only USDA-approved vaccine for botulism Type B in horses. The partnership aims to raise awareness among horse owners about the risks of botulism and the importance of preventive measures.
Why It's Important?
The renewed partnership between Neogen and US Equestrian highlights the critical need for education and prevention in equine health. Botulism poses a significant threat to horses, and increased awareness can help prevent outbreaks and protect equine athletes. This collaboration supports the broader goal of enhancing animal welfare and safety in the equestrian community. By providing resources and educational tools, Neogen and US Equestrian are empowering horse owners to take proactive steps in safeguarding their animals' health.
What's Next?
The partnership will continue to focus on educational outreach, with Neogen and US Equestrian developing new materials and resources for horse owners. This initiative may lead to further advancements in equine health research and the development of additional preventive measures. As awareness grows, the equestrian community could see improved health outcomes for horses and a reduction in botulism-related incidents.
